BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bioinformatics Software | QIAGEN Digital Insights - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bioinformatics Software | QIAGEN Digital Insights
X-ORIGINAL-URL:https://staging.digitalinsights.supremeclients.com
X-WR-CALDESC:Events for Bioinformatics Software | QIAGEN Digital Insights
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Dubai
BEGIN:STANDARD
TZOFFSETFROM:+0400
TZOFFSETTO:+0400
TZNAME:+04
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Rome
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Asia/Dubai:20241121T130000
DTEND;TZID=Asia/Dubai:20241121T140000
DTSTAMP:20260403T212543
CREATED:20241015T175251Z
LAST-MODIFIED:20241023T210055Z
UID:10000818-1732194000-1732197600@staging.digitalinsights.supremeclients.com
SUMMARY:New feature: Navigating datasets with OmicSoft Explorer
DESCRIPTION:Meet OmicSoft Explorer\, a new feature included with your QIAGEN IPA/OmicSoft subscriptions. See how you can find ‘omics datasets to inform your next experiments or support your grant proposals. \nWith OmicSoft Explorer\, you can: \n\nSearch over 10\,000 disease-relevant datasets for clinical\, in vitro\, normal tissue and more\nReveal top differentially expressed genes from over 200\,000 experiments\nDiscover experiments that include your gene of interest\nExplore underlying biology through IPA Interpret
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/new-feature-navigating-datasets-with-omicsoft-explorer/
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Dubai:20241120T130000
DTEND;TZID=Asia/Dubai:20241120T140000
DTSTAMP:20260403T212543
CREATED:20241015T175057Z
LAST-MODIFIED:20241023T210126Z
UID:10000817-1732107600-1732111200@staging.digitalinsights.supremeclients.com
SUMMARY:New feature: Insights with IPA Interpret
DESCRIPTION:Unlock actionable insights in your biological data by streamlining your data interpretation with IPA Interpret. \nThe newest feature of your trusted pathway analysis software\, QIAGEN IPA\, includes: \n\nContent powered by IPA's extensive\, manually curated knowledge base and aided by AI\nEasy-to-share reports and updated visualizations to facilitate collaboration and dissemination of research findings\nEasy access from your favorite web browser\, no additional software or hardware needed
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/new-feature-insights-with-ipa-interpret/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Dubai:20241119T130000
DTEND;TZID=Asia/Dubai:20241119T143000
DTSTAMP:20260403T212543
CREATED:20241015T174847Z
LAST-MODIFIED:20241024T183126Z
UID:10000816-1732021200-1732026600@staging.digitalinsights.supremeclients.com
SUMMARY:Investigating genomic variants using QIAGEN CLC Genomics Workbench\, QCI Interpret-Translational (QCII-T)\, and Ingenuity Pathway Analysis (IPA)
DESCRIPTION:Discovery of new genes implicated in hereditary diseases or cancer progression is challenging and advancing rapidly with an increase in the amount of cohort data to analyze from next generation sequencing (NGS) data to associations between gene variants and diseases\, and finally to biological mechanisms of these gene variants. Combining QIAGEN CLC Genomics Workbench\, QCII-T\, and IPA\, scientists can analyze sequencing data obtained from a variety of NGS technologies\, annotate gene variants using the world’s most comprehensive and up-to-date curated scientific evidence\, and find biological connections in gene variants with manually curated scientific findings. Get valuable and reliable insights for your research project and speed up your discoveries by using a streamlined NGS analysis workflow. \nIn this webinar\, attendees will have the opportunity to: \n\nLearn how to import whole genome or exome sequencing data into QIAGEN CLC Genomics Workbench and use the ultra-fast LightSpeed Module that delivers end-to-end NGS FASTQ to VCF pipeline;\nExplore capabilities in QCII-T which can enable scientists to accelerate discoveries from hereditary or tumor cohort analyses to find associations between gene variants and diseases;\nLearn how to use IPA and its manually curated content among other integrated scientific evidence to uncover novel biological mechanisms underlying these gene variants.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/investigating-genomic-variants-using-qiagen-clc-genomics-workbench-qci-interpret-translational-qcii-t-and-ingenuity-pathway-analysis-ipa/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Event
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20241119T080000
DTEND;TZID=UTC:20241123T170000
DTSTAMP:20260403T212543
CREATED:20240923T190720Z
LAST-MODIFIED:20241024T183125Z
UID:10000812-1732003200-1732381200@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN at AMP 2024
DESCRIPTION:Meet QIAGEN at the 2024 Association for Molecular Pathology (AMP) Annual Meeting\nThis year at the 2024 Association for Molecular Pathology (AMP) Annual Meeting\, QIAGEN will showcase our barrier-breaking Sample to Insight Oncology solution. Combining targeted DNA and multimodal pan-cancer panels\, one of the fastest and cheapest secondary analysis solutions in the market\, and industry-leading variant interpretation and reporting software trusted to analyze and interpret over 4 million NGS patient test cases worldwide\, our Sample to Insight Oncology solution is revolutionizing precision oncology testing. \nLean more and schedule a VIP meeting with our experts at AMP 2024 here.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-at-amp-2024/
CATEGORIES:Clinical,Event
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/10/S_1385_7_QDI_QCI_Skyline_Vancouver_pexels2416602.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241114T130000
DTEND;TZID=America/Halifax:20241114T143000
DTSTAMP:20260403T212543
CREATED:20240919T162936Z
LAST-MODIFIED:20241024T183120Z
UID:10000807-1731589200-1731594600@staging.digitalinsights.supremeclients.com
SUMMARY:Checkpoint inhibitor and immuno-oncology investigation leveraging curated high-quality public ‘omics data
DESCRIPTION:While there is great interest in the scientific community to investigate drug targets and biomarkers from public immune-oncology data\, such investigation is hindered by the difficulty in finding and combining related datasets to perform large-scale meta-analyses. This webinar will focus on how high-quality curated genomic repositories such as QIAGEN OmicSoft Lands immediately allows in-depth investigations across diverse data sources (GEO\, CPTAC\, TCGA\, GTEx and more) to discover and validate candidate checkpoint inhibitor drug targets and biomarkers. \nYou will learn how to do the following in the graphical user interface and through APIs: \n\nEasily identify relevant samples using extensive manually curated clinical metadata\nVisualize and identify checkpoint inhibition biology-related drug target and biomarkers expression patterns using expression data (RNA-seq\, scRNA-seq\, proteomics etc.)\nReveal how the expression of a group of biomarkers (or genes/proteins of interest) correlates in normal and disease tissue
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/checkpoint-inhibitor-and-immuno-oncology-investigation-leveraging-curated-high-quality-public-omics-data/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/10/S_1063_9_OmicSoft-Single-Cell-Lands_028687_16x9-1-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241113T100000
DTEND;TZID=America/New_York:20241113T110000
DTSTAMP:20260403T212543
CREATED:20241023T175035Z
LAST-MODIFIED:20241024T183129Z
UID:10000821-1731492000-1731495600@staging.digitalinsights.supremeclients.com
SUMMARY:Webinar: Pharmacogenomics - One tool to decode drug response to variation in the genome
DESCRIPTION:Each year\, more than 134 million patients experience adverse drug events\, causing 2.4 million deaths worldwide. What if there was a better way to develop and prescribe safer\, more effective drugs based on the unique genetic information of every individual? \nIn this webinar\, learn about a game-changing solution for labs and pharmaceutical companies to rapidly and confidently translate complex pharmacogenomics (PGx) data into evidence-backed insights to inform therapeutic outcomes. QIAGEN Pharmacogenomic Insights (PGXI) is a new expert-curated knowledgebase solution that provides comprehensive access to verified and up-to-date data from multiple PGx sources\, including the FDA\, CPIC\, DPWG\, PharmVar\, and PubMed. Built upon a legacy platform used to deliver more than 1.6 million PGx annotations for more than 250 clinical research laboratories\, PGXI seamlessly integrates into existing or new workflows to automate the annotation of PGx data from all platforms\, including NGS and arrays. Within minutes\, users can retrieve a custom output of relevant information\, including relevant conditions associated with queried genes of interest\, relevant drug-gene associations\, and curated literature evidence for alleles in question. \nIn this webinar\, you will learn: \n\nHow PGXI can help your lab efficiently and consistently identify medications associated with adverse effects.\nWhat expert-curated content sources are available in PGXI\, eliminating the need to consult multiple databases and saving you significant time and money.\nHow to use PGXI to seamlessly scale your PGXI workflow and stay at the cutting edge of PGx research.\n\nPlus\, if eligible\, webinar attendees can try PGXI for free with an exclusive trial offer from QIAGEN. There’s an easier and faster way to translate PGx data into insights. Don’t miss this opportunity to elevate and transform your PGx program. \nLearn more and register here.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/webinar-a-game-changer-for-pharmacogenomics-one-tool-to-decode-drug-response-to-variation-in-the-genome/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/10/S_1419_4_QDI_QCI_PGXI_Launch.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241112T130000
DTEND;TZID=America/Halifax:20241112T143000
DTSTAMP:20260403T212543
CREATED:20240919T155400Z
LAST-MODIFIED:20241024T183120Z
UID:10000806-1731416400-1731421800@staging.digitalinsights.supremeclients.com
SUMMARY:Discover biomarkers\, validate targets and identify variants with QDI software
DESCRIPTION:Learn how to leverage solutions from QIAGEN Digital Insights to discover biomarkers\, validate targets\, and identify variants. \nAttendees will learn to: \n\nLocate public studies of interest using OmicSoft DiseaseLand\nInvestigate expression of genes of interest across different treatments\, disease states\, etc.\nIdentify variants of interest for candidate biomarkers and targets using Human Gene Mutation Database (HGMD)\nLeverage the QIAGEN Knowledgebase in Ingenuity Pathway Analysis (IPA) to explore and extend findings from OmicSoft DiseaseLand and HGMD\nAccess data from OmicSoft\, HGMD and IPA in ways that are helpful for data scientists
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/discover-biomarkers-validate-targets-and-identify-variants-with-qdi-software/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1188_7_QDI_QDI_OmicSoft.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Dubai:20241107T130000
DTEND;TZID=Asia/Dubai:20241107T143000
DTSTAMP:20260403T212543
CREATED:20241015T174009Z
LAST-MODIFIED:20241024T183126Z
UID:10000815-1730984400-1730989800@staging.digitalinsights.supremeclients.com
SUMMARY:Support Session for IPA Certification
DESCRIPTION:Join us for a 90-minute LIVE group session designed to address different technical questions regarding IPA certification. QIAGEN IPA scientists will answer different IPA related technical questions and clarify various topics per requests of IPA certification participants. If possible\, please register for this session and let us know your questions by November 4\, 2024. \nPlease note: \n\nWe strongly encourage you to submit your questions ahead of time through this registration form.\nWhile questions submitted through this registration ahead of time will be prioritized\, we will try to answer as many questions as possible in these 90 min.\nThe purpose of this session is NOT for QIAGEN scientist to answer IPA certification exam questions but rather explain concepts surrounding these questions. Example\, for exam question asking how many molecules are mapped vs unmapped in the exam dataset\, the QIAGEN scientist will not give you the number but if asked\, will go over relevant steps of the data upload process.\nOnly those who signed up for IPA certification are invited to this session.\n\nQuestions we have so far: \n\nExplain course structure and exam related details.\nGo over recent update (RNA-seq analysis portal\, new pathways\, GWAS etc.) and cover this in context of this course.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/support-session-for-ipa-certification/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20241107T110000
DTEND;TZID=UTC:20241107T130000
DTSTAMP:20260403T212543
CREATED:20240923T171152Z
LAST-MODIFIED:20241024T183121Z
UID:10000808-1730977200-1730984400@staging.digitalinsights.supremeclients.com
SUMMARY:Exclusive Interactive Workshop: Master Clinical Variant Interpretation with QCI Interpret for Oncology
DESCRIPTION:An exclusive hands-on workshop to try QCI Interpret for Oncology\nFor US-based labs interested in learning more about QCI Interpret for Oncology\, QIAGEN’s clinical decision support software for variant interpretation and reporting\, we are hosting an exclusive\, interactive virtual workshop where you can access and demo the software for free. Each attendee will be given a temporary license and a VCF file to run a case on the industry-leading software. Through a guided session\, you will be able to see first-hand how QCI Interpret works\, with full exploration of the software’s capabilities and features. \nIn this workshop\, you will see how QCI Interpret: \n• Dynamically computes pathogenicity and actionability based on the ACMG and AMP/ASCO/CAP guidelines for every variant in all cancer types with full transparency. \n• Provides access to over 500\,000 pre-formulated\, oncologist-reviewed variant interpretation summaries to build customizable\, oncologist-ready reports. \n• Effortlessly streamlines case reviews by automatically selecting reportable variants\, along with tailored treatments and trials. \nOnly 40 spots available. Must apply by October 25\, 2024. \nThis workshop is an exclusive event limited to a select number of participants. To register\, you must provide a work email and be selected by QIAGEN to attend. The workshop will be hosted on a US server and no customer data will be involved. \nLearn more and register here.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/exclusive-interactive-workshop-master-clinical-variant-interpretation-with-qci-interpret-for-oncology/
CATEGORIES:Clinical,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/10/S_5731_NGS_QCI_s-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20241106T130000
DTEND;TZID=UTC:20241106T150000
DTSTAMP:20260403T212543
CREATED:20241015T172634Z
LAST-MODIFIED:20241024T183126Z
UID:10000814-1730898000-1730905200@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN IPA new user training
DESCRIPTION:Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in expanding your skill set? Join us as we learn more on large dataset analysis and knowledge base queries using QIAGEN IPA. \nYou’ll learn how to: \n\nUpload multiple dataset types (e.g.\, RNA-seq\, proteomics\, metabolomics) and perform interactive core/pathway analysis in IPA\nInterpret different results\, including pathways\, key regulators\, impact on biological functions/diseases and more\nCompare different experimental conditions (e.g.\, single-cell clusters\, disease types) and identify similarities and contrasts\nGenerate a network for hypothesis generation\, even without a dataset or experimental design\n\nAlready have an IPA license? Install IPA and start using it now. \nLearn more about IPA or request a free trial.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-ipa-new-user-training-3/
LOCATION:Virtual - Americas - EST\, United States
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241105
DTEND;VALUE=DATE:20241110
DTSTAMP:20260403T212543
CREATED:20240923T190008Z
LAST-MODIFIED:20241024T183125Z
UID:10000811-1730764800-1731196799@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN at ASHG 2024
DESCRIPTION:Meet QIAGEN at the 2024 American Society of Human Genetics (ASHG) Annual Meeting\nThis year at the 2024 American Society of Human Genetics (ASHG) Annual Meeting\, QIAGEN will showcase our Sample to Insight solutions for human genetics and inherited disease applications. From digital PCR technologies and actionable exome panels to one of the fastest and cheapest secondary analysis solutions in the market and industry-leading variant interpretation and reporting software trusted to analyze and interpret over 4 million NGS patient test cases worldwide\, our Sample to Insight solutions are revolutionizing genetic testing. \nLearn more and schedule a VIP meeting with our experts at ASHG 2024 here.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-at-ashg-2024/
CATEGORIES:Clinical,Event
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/10/pexels-noelace-16108565-scaled-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241029
DTEND;VALUE=DATE:20241031
DTSTAMP:20260403T212543
CREATED:20240923T185323Z
LAST-MODIFIED:20241024T183124Z
UID:10000810-1730160000-1730332799@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN at the Precision Medicine Forum Berlin
DESCRIPTION:Meet QIAGEN at the Precision Medicine Forum Berlin\nThis year at the 2024 Precision Medicine Forum Berlin\, QIAGEN will showcase our barrier-breaking Sample to Insight Oncology solution. Combining targeted DNA and multimodal pan-cancer panels\, one of the fastest and cheapest secondary analysis solutions in the market\, and industry-leading variant interpretation and reporting software trusted to analyze and interpret over 4 million NGS patient test cases worldwide\, our Sample to Insight Oncology solution is revolutionizing precision oncology testing. \nLearn more and register here.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-at-the-precision-medicine-forum-berlin/
LOCATION:Berlin\, Germany
CATEGORIES:Clinical,Event
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/10/S_1385_5_QDI_QCI_Slyline_Berlin_pexels19297608-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241024T130000
DTEND;TZID=America/Halifax:20241024T143000
DTSTAMP:20260403T212543
CREATED:20240919T153809Z
LAST-MODIFIED:20241024T183119Z
UID:10000805-1729774800-1729780200@staging.digitalinsights.supremeclients.com
SUMMARY:2024 update: Long reads analysis with QIAGEN CLC Genomics Workbench
DESCRIPTION:This webinar will introduce users to the long read support plugin for Oxford Nanopore and PacBio sequencing reads in QIAGEN CLC Genomics Workbench. \nParticipants will learn how to: \n\nDownload and install needed plugins\nImport data required for the analysis\nPerform long read de novo assembly\nMap reads to a reference and visualize an assembly\nUse BLAST to investigate the contigs\nUse additional long read tools: polish with short reads\, structural variant calling\nUse genome finishing tools: analyze and assemble contigs\nUse analytical tools: RNA-seq analysis for long reads\, classify long read amplicons for metagenomics
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/2024-update-long-reads-analysis-with-qiagen-clc-genomics-workbench/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1040_8_QDI_CLC_GWBv21_Gi470306612_16x9_Large-1200px_53596-768x432-1-1-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20241023T100000
DTEND;TZID=UTC:20241023T110000
DTSTAMP:20260403T212543
CREATED:20241015T232603Z
LAST-MODIFIED:20241024T183127Z
UID:10000820-1729677600-1729681200@staging.digitalinsights.supremeclients.com
SUMMARY:Master HGMD Professional: Virtual Training Session
DESCRIPTION:Back by popular demand\, our live\, interactive HGMD Professional sessions are designed to help you master the skills needed to navigate and use the industry-leading database like an expert. This virtual training session will show you how to effectively leverage the extensive features and functionalities of HGMD Professional compared to its public counterpart. \nAttendees will learn how to: \n\n\n\n\n\nDistinguish clinically relevant variants from variants of unknown significance (VUS)\n\n\n\n\n\n\nCurate genes using HGMD Professional’s accurate\, up-to-date evidence\n\n\n\n\n\n\nIdentify the predominant genetic variant in a specific gene to understand the genetic mechanisms underlying associated diseases\nUse batch search vs advanced search when you need to query a large number of mutations or variants at once.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/master-hgmd-professional-virtual-training-session/
CATEGORIES:Clinical,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/10/HGMD-2024.3-002.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241017T130000
DTEND;TZID=America/Halifax:20241017T143000
DTSTAMP:20260403T212543
CREATED:20240919T153150Z
LAST-MODIFIED:20241024T183118Z
UID:10000804-1729170000-1729175400@staging.digitalinsights.supremeclients.com
SUMMARY:Introducing the RNA-seq Analysis Portal in QIAGEN IPA
DESCRIPTION:Get to know the RNA-seq Analysis Portal\, a cloud-based platform you can access from within QIAGEN Ingenuity Pathway Analysis (IPA) that helps you analyze your RNA-seq expression data. Its predefined analysis pipelines let you calculate expression levels and identify differential expression and significant pathways\, regulators\, diseases and functions in just a few steps. The graphical views and interactive plots enable seamless exploration and refinement of your RNA-seq analysis results. \nIn this training you will learn how to: \n\nUpload your own expression data (example raw FASTQ files) or start with a public dataset\nPerform RNA-seq analysis and generate outputs such as heatmap\, differential expression table\, volcano plot and more\nExport graphical and tabular results\n\nLearn more about the IPA RNA-seq Analysis Portal.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/introducing-the-rna-seq-analysis-portal-in-qiagen-ipa/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/10/CILLU_0221_LS_GG_RNA_seq_analysis.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20241016T140000
DTEND;TZID=UTC:20241016T150000
DTSTAMP:20260403T212543
CREATED:20241015T225810Z
LAST-MODIFIED:20241024T183127Z
UID:10000819-1729087200-1729090800@staging.digitalinsights.supremeclients.com
SUMMARY:Master HGMD Professional: Virtual Training Session
DESCRIPTION:Back by popular demand\, our live\, interactive HGMD Professional sessions are designed to help you master the skills needed to navigate and use the industry-leading database like an expert. Offered on two dates—October 16\, 2024\, and October 23\, 2024—these virtual training sessions will show you how to effectively leverage the extensive features and functionalities of HGMD Professional compared to its public counterpart. \nAttendees will learn how to: \n\n\n\n\n\nDistinguish clinically relevant variants from variants of unknown significance (VUS)\n\n\n\n\n\n\nCurate genes using HGMD Professional’s accurate\, up-to-date evidence\n\n\n\n\n\n\nIdentify the predominant genetic variant in a specific gene to understand the genetic mechanisms underlying associated diseases\n\n\n\n\n\n\nUse batch search vs advanced search when you need to query a large number of mutations or variants at once.\n\n\n\n  \nCan't make Session 1? Register for Session 2 on October 23 here.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/master-hgmd-professional-virtual-training-session-1/
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/10/HGMD-2024.3-002.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241016T130000
DTEND;TZID=America/Halifax:20241016T150000
DTSTAMP:20260403T212543
CREATED:20240919T151233Z
LAST-MODIFIED:20241024T183113Z
UID:10000800-1729083600-1729090800@staging.digitalinsights.supremeclients.com
SUMMARY:Gene therapy applications through knowledge graph explorations
DESCRIPTION:In gene therapy space\, there is great interest in discovering new gene editing targets as well as identifying new indications for known targets though exploration of vector biology and studying biological mechanism underlying disease pathology. In this webinar\, we will focus on how recently introduced Biomedical KB-AI can enable and accelerate such investigation. QIAGEN Biomedical KB-AI uses generative AI to identify novel relationships and patterns that may be missed by traditional methods and can provide a more comprehensive view of the biological landscape. Participants will learn about: \n\nBiomedical KB-AI and its structure\nHow to easily search and filter results for vector system of interest through subgraph\nHow to thoroughly interrogate the subgraph to look for similarity between diseases and targets that can be targeted by vectors of interest\nHow to effectively use knowledge graph for drug repurposing applications
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/gene-therapy-applications-through-knowledge-graph-explorations/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1212_8_QDI_QDI_BKB_Original_62142.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241014
DTEND;VALUE=DATE:20241017
DTSTAMP:20260403T212543
CREATED:20240923T184432Z
LAST-MODIFIED:20241024T183124Z
UID:10000809-1728864000-1729123199@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN at VEPTC 2024
DESCRIPTION:Meet QIAGEN at the Variant Effect Prediction Training Course (VEPTC)\nThis year at the 2024 Variant Effect Prediction Training Course (VEPTC)\, QIAGEN will be showcasing our industry-leading next-generation sequencing (NGS) variant analysis\, interpretation and reporting solutions. Trusted to analyze and interpret more than 4 million NGS patient test cases\, QIAGEN Clinical Insight (QCI) is the industry’s leading clinical decision support platform by volume. Find out why nobody does variant analysis and interpretation better than QIAGEN at VEPTC 2024. \nLearn more and schedule a VIP meeting with our experts at VEPTC 2024 here.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-at-veptc-2024-2/
LOCATION:Palermo\, Italy
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/10/pexels-inmaculada-pena-567266-14213525-scaled-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20241010T110000
DTEND;TZID=UTC:20241010T120000
DTSTAMP:20260403T212543
CREATED:20240930T165834Z
LAST-MODIFIED:20241024T183125Z
UID:10000813-1728558000-1728561600@staging.digitalinsights.supremeclients.com
SUMMARY:Webinar: Streamline your hereditary diseases interpretation workflow with QCI Interpret
DESCRIPTION:Learn how QCI Interpret\, clinical decision support software for variant interpretation and reporting\, can help your lab rapidly identify pathogenic variants\, improve diagnostic yields\, and significantly reduce test turnaround time for hereditary diseases. Attendees will receive a demonstration of QCI Interpret’s unique capabilities and advanced features for germline variant interpretation with example workflows for carrier screening and whole-exome sequencing panels. Key highlights will include how your lab can expedite variant interpretation by leveraging the most extensive\, manually curated knowledge base\, dynamically compute pathogenicity based on ACMG guidelines for every variant with full transparency\, and leverage QCI Interpret’s proprietary augmented molecular intelligence approach to literature curation and variant classification to streamline your interpretation workflow. \nIn this webinar\, attendees will: \n\nReceive a demonstration of QCI Interpret’s analysis and interpretation workflows for hereditary diseases using targeted and extended gene panels\, including whole-genome and whole-exome sequencing.\nLearn about QIAGEN’s proprietary expert curation process for the knowledge base in QCI Interpret.\nExplore unique time-saving features within QCI Interpret\, including phenotype-driven ranking and automation of ACMG guidelines.\nUnderstand how QCI Interpret supports copy number variant (CNV) interpretation and reporting with bibliographic coverage of over 60\,000 CNV case reports.\n\n\n\n\nSpeaker: \n\n\n\n\nElias Hage\, PhD\nAssociate Director\, Global Product Management\nQIAGEN Digital Insights\n\n\nElias Hage\, PhD\, is the Associate Director of Global Product Management for Hereditary Disease and Oncology Applications at QIAGEN Digital Insights (QDI). In this role\, he oversees the development\, management\, and optimization of QDI software\, databases and services for genomic analysis and interpretation of hereditary disease and oncology cases. Prior to joining QDI\, Dr. Hage served as a Global Product Manager at Agilent Technologies\, where he managed the Genomics division flagship SaaS application (Alissa Interpret) and supported its usage globally in both research and IVD settings. Dr. Hage obtained his Ph.D. in virology and genomics from Hannover Medical School in Belgium.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/webinar-streamline-your-hereditary-diseases-interpretation-workflow-with-qci-interpret/
LOCATION:Virtual Global Event (Times shown in EST)
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1327_8_QDI_QCI_Hereditary_Gi1346512014.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241008T130000
DTEND;TZID=America/Halifax:20241008T140000
DTSTAMP:20260403T212543
CREATED:20240919T151623Z
LAST-MODIFIED:20241024T183114Z
UID:10000801-1728392400-1728396000@staging.digitalinsights.supremeclients.com
SUMMARY:How to triage drug targets with curated\, causal relationships data
DESCRIPTION:In the rapidly evolving landscape of drug discovery\, the ability to integrate high-quality research findings into knowledge graphs is paramount. For over twenty years\, our scientists have curated the relationships between genes\, drugs\, diseases\, and pathways to power Ingenuity Pathway Analysis. Now\, these data are available via our QIAGEN Biomedical KB-HD\, which provides direct access to flat files\, SQL APIs in Python and R\, and the ability to export knowledge graph objects for analysis in Neo4j. In this talk\, we will explore how to use this rich data resource to: \n\naggregate relevant findings across our comprehensive disease and gene ontologies\ncross-reference clinical trial results to focus your research on genes upstream or downstream of known drug targets\nfilter causal relationships by the directionality of observed effects\ncombine the above methods to accelerate the drug discovery process\n\nBy demonstrating the underlying database live\, we will show how the high-quality curated biomedical knowledge bases can be rapidly deployed\, as well as how the underlying schema and ontologies could serve as a scaffold for integrating your own research. Overall\, this demonstration will show the critical role of knowledge graphs in finding viable drug targets while avoiding potential adverse outcomes and toxicity.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/how-to-triage-drug-targets-with-curated-causal-relationships-data/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1212_8_QDI_QDI_BKB_Original_62142.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20241007T140000
DTEND;TZID=UTC:20241007T153000
DTSTAMP:20260403T212543
CREATED:20240919T151918Z
LAST-MODIFIED:20241024T183115Z
UID:10000802-1728309600-1728315000@staging.digitalinsights.supremeclients.com
SUMMARY:RNA-seq data analysis and interpretation with Sankey plot update
DESCRIPTION:For RNA-seq data\, you will learn how to: \n\nImport FASTQ files\, cell matrix files and metadata and how to download references\nMap reads to a reference genome and generate gene and transcript counts and QC reports displaying % mapped reads\, knee plots\, etc.\nGenerate visualizations of results\, such as heatmaps\, differential expression tables\, PCA/PCOA plots\, Venn diagrams\, sankey plot and others\nEasily customize RNA-seq workflows\nExport publication-quality graphics\, tables and reports\nSend differential expression tables to QIAGEN Ingenuity Pathway Analysis directly from QIAGEN CLC Genomics Workbench to analyze and interpret relevant pathways
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/rna-seq-data-analysis-and-interpretation-with-sankey-plot-update-3/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241003T130000
DTEND;TZID=America/Halifax:20241003T150000
DTSTAMP:20260403T212543
CREATED:20240919T152232Z
LAST-MODIFIED:20241024T183117Z
UID:10000803-1727960400-1727967600@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN IPA new user training
DESCRIPTION:Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in expanding your skill set? Join us as we learn more on large dataset analysis and knowledge base queries using QIAGEN IPA. \nYou’ll learn to: \n\nUpload multiple dataset types (e.g.\, RNA-seq\, proteomics\, metabolomics) and perform interactive core/pathway analysis in IPA\nLearn how to interpret different results\, including pathways\, key regulators\, impact on biological functions/diseases and more\nCompare different experimental conditions (e.g.\, single-cell clusters\, disease types) and identify similarities and contrasts\nGenerate a network for hypothesis generation\, even without a dataset or experimental design\n\nAlready have an IPA license? Install IPA and start using it now. \nLearn more about IPA or request a free trial.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-ipa-new-user-training-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240926T130000
DTEND;TZID=America/Halifax:20240926T143000
DTSTAMP:20260403T212543
CREATED:20240814T192314Z
LAST-MODIFIED:20241024T183059Z
UID:10000794-1727355600-1727361000@staging.digitalinsights.supremeclients.com
SUMMARY:Investigating biomarkers with bulk and single-cell RNA-seq expression data
DESCRIPTION:QIAGEN Ingenuity Pathway Analysis (IPA) is designed to help you analyze and compare different types of 'omics data. In this webinar\, we’ll compare bulk RNA-seq and single-cell RNA-seq data to identify common regulators/targets and see how those regulators/targets associate with your phenotype of interest. We will also use sample-level public data to validate gene expression of common genes in tissues and/or cell type of interest. \nYou'll learn how to: \n\nGenerate a Comparison Analysis for bulk and single-cell RNA-seq\nIdentify significant common genes with the Compare feature\nBuild a custom network associating common genes to a phenotype\nExamine sample- and cell-level expression in OmicSoft content
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/compare-bulk-rnaseq-and-single-cell-rnaseq-expression-data-for-biomarkers-investigation/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240926T110000
DTEND;TZID=UTC:20240926T123000
DTSTAMP:20260403T212543
CREATED:20240821T172900Z
LAST-MODIFIED:20241024T183100Z
UID:10000795-1727348400-1727353800@staging.digitalinsights.supremeclients.com
SUMMARY:Third Annual Clinical Hereditary Disease Diagnostics Summit "Exome experts: Improving the interpretation and integration of exome testing in routine clinical care"
DESCRIPTION:Industry leaders discuss how to improve the speed\, precision and cost-effectiveness of clinical exome testing for newborn screening and rare and undiagnosed diseases \nClinical exome testing is revolutionizing the diagnosis of rare and inherited diseases. Its ability to quickly pinpoint the genetic causes of complex conditions has made it a critical component of personalized medicine\, leading to earlier diagnoses\, targeted treatments and improved patient outcomes. However\, without the right strategies\, databases and informatics tools\, clinical exome testing remains inaccessible for many small to mid-sized laboratories. \nThe Third Annual Clinical Hereditary Disease Diagnostics Summit hosted by QIAGEN Digital Insights will examine the incredible opportunities—and challenges—of brining clinical exome testing in-house. Join industry leaders as they discuss how labs\, regardless of size\, budget and experience\, can integrate exome testing into routine clinical care with transformative impact for providers and their patients. \nFeatured topics will include: \n\nEmerging trends and recent technological advancements in genetic testing\nOvercoming challenges of interpreting complex genetic data from genome\, exome\, and next-generation sequencing panels\nHow to integrate genetic testing into clinical practice with consideration of efficiency\, cost\, and ethics\nFuture directions for the field and how to prepare your lab for innovation
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/exome-experts-improving-the-interpretation-and-integration-of-exome-testing-in-routine-clinical-care/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240917T130000
DTEND;TZID=America/Halifax:20240917T143000
DTSTAMP:20260403T212543
CREATED:20240814T185750Z
LAST-MODIFIED:20241024T183055Z
UID:10000787-1726578000-1726583400@staging.digitalinsights.supremeclients.com
SUMMARY:OmicSoft Diseaseland Training
DESCRIPTION:Per feedback of scientists interested in taking advantage of non-oncological diseases (inflammatory\, infectious\, metabolic and more) as well as normal tissues (example toxicology/target safety assessment) omics\, we are hosting this training focused OmicSoft Diseaseland. OmicSoft Diseaseland is a repository which contain high quality curated ‘omic data (RNA-seq\, scRNA-seq\, microarray and more) from diverse data-sources (example GEO\, SRA\, GTEx and many more). While this training will be focused on leveraging public data\, users can use this knowledge to navigate through their institution’s internal lands (omic data repositories) as well. \nAttendees will learn to perform queries similar to below \n\nHow is a gene (or a set of genes) expressed across different conditions? (Conditions = diseases\, tissues\, treatments\, cell types and more)\nHow is expression of a gene correlated with expression of other genes?\nFor a list of genes can we generate a heatmap studying their expression across different conditions?\nHow do you get a list of biomarkers specific to a condition from public studies?
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/omicsoft-diseaseland-training/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1188_7_QDI_QDI_OmicSoft.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240912T110000
DTEND;TZID=UTC:20240912T120000
DTSTAMP:20260403T212543
CREATED:20240821T173902Z
LAST-MODIFIED:20241024T183100Z
UID:10000796-1726138800-1726142400@staging.digitalinsights.supremeclients.com
SUMMARY:Expanding neoantigen discovery with COSMIC
DESCRIPTION:Neoantigens are among the newest promising targets for cancer treatment. Unlike tumor-associated antigens\, neoantigens are produced only by tumor cells. These unique molecular markers are highly visible to the immune system\, making them ideal for personalized immunotherapies. They may also be able to predict both tumor survival prognosis and immune checkpoint blockade responses. Neoantigens are presented by human leukocyte antigen class I molecules (HLA-I) to T cells\, providing an ideal pathway for detection by shotgun proteomics. To identify these elusive targets\, scientists often rely on whole exome sequencing (WES)-derived data. However\, this approach can miss rare or low-frequency mutations\, especially in cancers with a low tumor mutational burden (TMB). \nThe Catalogue of Somatic Mutations in Cancer (COSMIC) can bridge this gap by providing researchers with detailed information about somatic mutations in human cancer. Unlock the full potential of neoantigen-targeted therapies and enhance traditional approaches like WES with our comprehensive\, expert-curated knowledge base. \nIn this webinar\, we’ll learn to: \n\nUncover and validate potential neoantigens with a recent peer-reviewed study that uses COSMIC mutation data from human hepatocellular carcinoma (HCC)\, a low-TMB cancer\nApply the benchmarking results of neoantigen detection performance using HCC-specific variants from COSMIC or DepMap\nTake full advantage of the breadth and accuracy of COSMIC data with downloaded content and other resources\n\nCOSMIC’s scientific and curation team will also answer your questions live during the webinar. \n  \nSpeaker: Kyle Nilson\, PhD \nKyle Nilson\, PhD\, is a sequencing-focused molecular biologist with a background in biochemistry and technical support. As a field software trainer at QIAGEN Digital Insights\, Dr. Nilson works closely with QIAGEN’s global bioinformatics team to provide direct customer support and assist with software training\, implementation\, and optimization. He earned his Ph.D. in molecular and cellular biology from the University of Iowa\, where he studied the regulation of RNA polymerase II transcription and co-transcriptional mRNA processing. Dr. Nilson then completed his postdoctoral training at Penn State and Cornell University\, focusing exclusively on next-generation sequencing method development to study chromatin.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/expanding-neoantigen-discovery-with-cosmic/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240910T130000
DTEND;TZID=America/Halifax:20240910T143000
DTSTAMP:20260403T212543
CREATED:20240814T190300Z
LAST-MODIFIED:20241024T183055Z
UID:10000788-1725973200-1725978600@staging.digitalinsights.supremeclients.com
SUMMARY:Metatranscriptome analysis\, annotation and pathways investigations using CLC Genomics Workbench
DESCRIPTION:Using CLC Genomics Workbench\, we will go through a pipeline for analyzing metatranscriptome NGS data from microbial communities and perform pathways interpretation on it. \n\nImport "raw" NGS sequencing data and prepare the samples for analysis\nFind relevant annotated genomes with a curated reference database while removing ribosomal RNA with the SILVA database (database of rRNAs)\nDe novo assemble the unclassified reads into contigs to also find transcripts of taxa not present in the reference database\nMap the reads to the assembled contigs and database · Build a functional profile of the samples to get an abundance of GO-terms.\nStatistical analysis of the groups\nPathway analysis on the differential abundance analysis using MetaCyc database.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/metatranscriptome-analysis-annotation-and-pathways-investigations-using-clc-genomics-workbench/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/10/0be0fc6f-c5b4-487a-8eb9-70ec50b6fad1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20240907T080000
DTEND;TZID=Europe/Helsinki:20240911T170000
DTSTAMP:20260403T212543
CREATED:20240829T162719Z
LAST-MODIFIED:20241024T183102Z
UID:10000799-1725696000-1726074000@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN presents poster at 2024 European Congress of Pathology
DESCRIPTION:QIAGEN will be at the 36th European Congress of Pathology (ECP) in Florence from September 7-11\, 2024\, in Florence\, Italy. \nAt the event\, be sure to check out our poster that we are presenting in collaboration with a leading pharmaceutical company showing how our clinical decision support software\, QCI Interpret\, provides rapid and accurate interpretation of gBRCA genes in a clinical lab setting. In the study\, 10 partner labs were asked to assess 48 retrospective analyses of BRCA variants and compare their variant classifications with the automated classifications computed by QCI Interpret. Results showed QCI Interpret was concordant with 93% of all cases. \n \nFeatured Poster: Spadolini Pavilion (Upper Floor) \nMolecular Pathology Session | September\, 10\, 2024\, 9:30–10:30 a.m. \nPoster number: 009. Title: “QIAGEN clinical decision support software provides rapid and accurate interpretation of gBRCA variants in a clinical lab setting”
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-36th-european-congress-of-pathology-ecp/
LOCATION:Florence\, Italy
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/10/S_1418_4_QDI_QCI_Italy_Florence.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240905T130000
DTEND;TZID=America/Halifax:20240905T140000
DTSTAMP:20260403T212543
CREATED:20240814T190613Z
LAST-MODIFIED:20241024T183055Z
UID:10000789-1725541200-1725544800@staging.digitalinsights.supremeclients.com
SUMMARY:Custom patient cohorts: Making discoveries with curated genomics data
DESCRIPTION:Are you interested in exploring how you can evaluate phenotypic differences between custom cohorts? You can learn more about drug response\, survival\, co-expressing biomarkers\, mutations and more based on gene expression. \nIn this webinar\, you'll learn how to investigate patient cohorts using high-quality curated genomic repositories like the QIAGEN OmicSoft Lands database. You'll be able to to perform in-depth investigations across diverse data-sources\, including GEO datasets\, TCGA and more. \nIn this webinar\, attendees will learn how to \n\nEasily locate studies of interest using OmicSoft Lands APIs\nGenerate custom cohorts based on expression levels of biomarker(s) of interest\nThoroughly investigate drug response and patient survival for these custom cohorts\nStudy variants/mutations present in these patient population and their association with disease pathology
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/discoveries-from-custom-patient-cohorts-drug-response-survival-curves-mutations-and-more-using-high-quality-genomics-public-data-and-peer-reviewed-literature/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1212_8_QDI_QDI_BKB_Original_62142.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240904T130000
DTEND;TZID=America/Halifax:20240904T150000
DTSTAMP:20260403T212543
CREATED:20240814T191059Z
LAST-MODIFIED:20241024T183058Z
UID:10000790-1725454800-1725462000@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN IPA new user training
DESCRIPTION:Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in expanding your skill set? Join us as we learn more on large dataset analysis and knowledge base queries using QIAGEN IPA. \nYou’ll learn to: \n\nUpload multiple dataset types (e.g.\, RNA-seq\, proteomics\, metabolomics) and perform interactive core/pathway analysis in IPA\nLearn how to interpret different results\, including pathways\, key regulators\, impact on biological functions/diseases and more\nCompare different experimental conditions (e.g.\, single-cell clusters\, disease types) and identify similarities and contrasts\nGenerate a network for hypothesis generation\, even without a dataset or experimental design\n\nAlready have an IPA license? Install IPA and start using it now. \nLearn more about IPA or request a free trial.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-ipa-new-user-training/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
END:VCALENDAR